focus -WSS

focus

author：knowledge 2025-09-29 20:51:30 - browse：626

Pascal Soriot - Senate Finance Committee — AstraZeneca CEO Pascal Soriot Jacquelyn Martin/AP

LONDON — Medicare’s first-ever drug pricing negotiations are officially underway. But neither government officials nor drugmakers are wanting to show their cards, at least publicly.

Last week, Medicare made its first offers to the makers of the 10 products subject to negotiation, though it said it would be up to the companies to discuss the proposals. On Thursday, at a press briefing at which they presented their 2023 earnings, AstraZeneca executives also played coy about the bargaining over the price of the company’s diabetes drug Farxiga.

“We have received the first offer, but as you can imagine, we will not disclose what the offer is,” Ruud Dobber, the company’s executive vice president of biopharmaceuticals business, said at the event, held at the London Stock Exchange. “We are in active negotiation, and it will be a few rounds of discussions” with Medicare.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Pfizer plans to depart BIO

focus

WSS

After sickle

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Newly revealed memo details efforts to keep Trump in power following election loss

In diabetes hearing, Sanders takes on a new foe: food makers

Teach medical students about patients with intellectual disabilities

The woman behind the Dana Farber

focus

focus

entertainment

Continuity nursing helped my family in our darkest PICU moments

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Malaria cases in Florida and Texas: Here’s what you need to know

CDC overhauls leadership of center that led response to Covid

Hollywood unions extend contract negotiations for actors

Leukemia patients are helped by Syndax's new type of therapy

As demand for Covid shots wanes, Moderna seeks its next success

Radiology is caught between AI's potential and concern for patients

Supreme Court strikes down use of affirmative action

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

knowledge

Americans' trust in science, scientist continues decline: Report

Where are patients getting their prescriptions for GLP

Roche to buy Carmot Therapeutics, developer of obesity drugs

Pharma budget tightening trickles down to Doximity

Radiology is caught between AI's potential and concern for patients

After John Oliver segment, STAT readers share their opioid

hotspot

leisure time

focus

focus